← Evidence map

TrialThe Journal of pharmacology and experimental therapeutics2016

Abuse Potential and Pharmacodynamic Characteristics of Oral and Intranasal Eluxadoline, a Mixed μ- and κ-Opioid Receptor Agonist and δ-Opioid Receptor Antagonist.

N Levy-Cooperman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

11 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27647873